Colonisation endpoints in Streptococcus pneumoniae vaccine trials.

Area of Science:

• Vaccinology
• Microbiology
• Epidemiology

Background:

• Evaluating vaccine efficacy for protection against colonization (VEcol) is increasingly important.
• Streptococcus pneumoniae colonization is a common, recurrent, and multi-type endpoint.
• Accurate definition and estimation of VEcol are critical for vaccine development.

Purpose of the Study:

• To review recent developments in estimating VEcol for Streptococcus pneumoniae.
• To provide practical guidelines for selecting estimands and estimation methods.
• To focus on methods suitable for cross-sectional study designs with single sample collection.

Main Methods:

• Review of recent statistical and epidemiological methods for VEcol estimation.
• Focus on cross-sectional study designs.
• Consideration of single nasopharyngeal sample analysis per subject.

Main Results:

• Colonization endpoints require careful definition of vaccine efficacy parameters.
• Specific estimation methods are suitable for cross-sectional designs.
• Guidelines are provided for choosing appropriate estimands and methods.

Conclusions:

• Effective estimation of VEcol for Streptococcus pneumoniae is feasible with appropriate methods.
• Cross-sectional designs with single samples can yield valuable VEcol data.
• Practical guidance aids researchers in designing vaccine trials with colonization endpoints.